arrow
S

Subha Madhavan

pfizer inc.
H指数:40
被引数:8,771

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Utilizing Immuno-Oncology registry data for enhanced non-small cell lung cancer treatment predictions

利用免疫肿瘤学登记数据以增强非小细胞肺癌治疗预测

2025-08-010
OAAI
Towards fair decentralized benchmarking of healthcare AI algorithms with the Federated Tumor Segmentation (FeTS) challenge

通过联合肿瘤分割 (FeTS) 挑战实现医疗AI算法的公平分散基准测试

2025-07-080
OAAI
The impact of immunosuppressive agents on immune checkpoint inhibitor efficacy in patients with advanced melanoma: A real-world, multicenter, retrospective study
CANCER
IF5.1
2023-03-237
PRE
Federated learning enables big data for rare cancer boundary detection (vol 13, 7346, 2022)
2023-01-263
OAAI
Federated learning enables big data for rare cancer boundary detection

联邦学习支持罕见癌症边界检测的大数据

2022-12-05110
OAAI
CIViCdb 2022: evolution of an open-access cancer variant interpretation knowledgebase
2022-11-1410
OAAI
Exploring approaches for predictive cancer patient digital twins: Opportunities for collaboration and innovation

探索预测性癌症患者数字双胞胎的方法: 合作与创新的机会

2022-10-0638
OAAI
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC) (vol 24, pg 986, 2022)
2022-09-015
PRE
A community approach to the cancer-variant-interpretation bottleneck
2022-05-274
OA
Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)

癌症体细胞变异的致病性分类标准 (致癌性): 临床基因组资源 (ClinGen),癌症基因组学联盟 (CGC) 和癌症变异解释联盟 (VICC) 的联合建议

2022-05-01111
OAAI
Genetic variants associated with childhood cancers: Curation initiatives of the ClinGen Somatic Cancer Pediatric Taskforce
2022-03-010
OA